YAZ

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa

Active ingredients

The drug YAZ contains a combination of these active pharmaceutical ingredients (APIs):

1 Drospirenone UNII N295J34A25 - DROSPIRENONE

Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone. Read about Drospirenone

2 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AA12	Drospirenone and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912050016313, 538912120021103, 538917100027503, 538917100027603, 538917100027703, 538917100027803
Country: CA	Health Products and Food Branch	Identifier(s): 02321157
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28242-08-07
Country: EE	Ravimiamet	Identifier(s): 1316090, 1316102, 1316113, 1476840
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70093
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 136584, 136595, 136607
Country: FR	Base de données publique des médicaments	Identifier(s): 61727306
Country: HK	Department of Health Drug Office	Identifier(s): 56563
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-604240169
Country: IE	Health Products Regulatory Authority	Identifier(s): 53035
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6485, 6486
Country: JP	医薬品医療機器総合機構	Identifier(s): 2482011F1020, 2482011F2027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027077, 1033484, 1033485, 1054467, 1090981
Country: MT	Medicines Authority	Identifier(s): MA639/00601, PI1438/06801A, PI1438/06801B
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105694
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13453
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100184244, 100374140, 100384606, 100392250, 100458291, 100460373
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64054001, W64054002, W64054003
Country: SG	Health Sciences Authority	Identifier(s): 13584P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/21.8.2/0842